The matrix in cancer

TR Cox - Nature Reviews Cancer, 2021 - nature.com
The extracellular matrix is a fundamental, core component of all tissues and organs, and is
essential for the existence of multicellular organisms. From the earliest stages of organism …

Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons

A Naimi, RN Mohammed, A Raji, S Chupradit… - Cell communication and …, 2022 - Springer
The main breakthrough in tumor immunotherapy was the discovery of immune checkpoint
(IC) proteins, which act as a potent suppressor of the immune system by a myriad of …

The current treatment paradigm for pancreatic ductal adenocarcinoma and barriers to therapeutic efficacy

DR Principe, PW Underwood, M Korc… - Frontiers in …, 2021 - frontiersin.org
Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis, with a median survival
time of 10-12 months. Clinically, these poor outcomes are attributed to several factors …

Context-specific determinants of the immunosuppressive tumor microenvironment in pancreatic cancer

C Falcomatà, S Bärthel, G Schneider, R Rad… - Cancer Discovery, 2023 - AACR
Immunotherapies have shown benefits across a range of human cancers, but not pancreatic
ductal adenocarcinoma (PDAC). Recent evidence suggests that the immunosuppressive …

The extracellular matrix: its composition, function, remodeling, and role in tumorigenesis

K Dzobo, C Dandara - Biomimetics, 2023 - mdpi.com
The extracellular matrix (ECM) is a ubiquitous member of the body and is key to the
maintenance of tissue and organ integrity. Initially thought to be a bystander in many cellular …

Tumor-homing and immune-reprogramming cellular nanovesicles for photoacoustic imaging-guided phototriggered precise chemoimmunotherapy

Z Fan, Y Wang, L Li, F Zeng, Q Shang, Y Liao… - ACS …, 2022 - ACS Publications
Many studies have focused on develo** effective therapeutic strategies to selectively
destroy primary tumors, eliminate metastatic lesions, and prevent tumor recurrence with …

The importance of 3D fibre architecture in cancer and implications for biomaterial model design

JC Ashworth, TR Cox - Nature Reviews Cancer, 2024 - nature.com
The need for improved prediction of clinical response is driving the development of cancer
models with enhanced physiological relevance. A new concept of 'precision biomaterials' is …

METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinoma

X Zeng, F Zhao, G Cui, Y Zhang, RA Deshpande… - Nature Cancer, 2022 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers.
Characterization of genetic alterations will improve our understanding and therapies for this …

Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment

YH Zhu, JH Zheng, QY Jia, ZH Duan, HF Yao, J Yang… - Cellular Oncology, 2023 - Springer
Pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer, is
characterized by poor treatment response and low survival time. The current clinical …

Multifunctional lipid bilayer nanocarriers for cancer immunotherapy in heterogeneous tumor microenvironments, combining immunogenic cell death stimuli with …

AE Nel, KC Mei, YP Liao, X Liu - ACS nano, 2022 - ACS Publications
In addition to the contribution of cancer cells, the solid tumor microenvironment (TME) has a
critical role in determining tumor expansion, antitumor immunity, and the response to …